Showing results (971-980 of 1,707) with videos related to
Sort By:
Pageof 171
Evolutionary Applications|October 2, 2020
Can CRISPR gene drive work in pest and beneficial haplodiploid species?Jun Li, Ofer Aidlin Harari, Anna-Louise Doss, et al.Intensive Care Medicine Experimental|February 11, 2022
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failureIrene T Schrijver, Eleni Karakike, Charlotte Théroude, et al.Annals of Epidemiology|August 12, 2020
Spatiotemporal distribution of autism spectrum disorder prevalence among birth cohorts during 2000-2011 in IsraelHadas Magen-Molho, Ruthie Harari-Kremer, Ofir Pinto, et al.Chemical Science|February 7, 2025
Molecular Aharonov-Bohm-type interferometers based on porphyrin nanoringsChi Y Cheng, Gil Harari, Igor Rončević, et al.Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.American Journal of Otolaryngology|August 20, 2010
Head and neck squamous cell carcinoma from an unknown primary siteAudrey Wallace, Greg M Richards, Paul M Harari, et al.Coronary Artery Disease|July 17, 2015
Effect of coronary artery disease severity and revascularization completeness on 2-year clinical outcomes in patients undergoing transcatether aortic valve replacementGuy Witberg, Ifat Lavi, Emmanuel Harari, et al.Cancer Research|April 19, 2005
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)Prakash Chinnaiyan, Shyhmin Huang, Geetha Vallabhaneni, et al.Respiratory Medicine|May 5, 2018
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study designJürgen Behr, Steven D Nathan, Sergio Harari, et al.European Journal of Internal Medicine|February 25, 2009
Bosentan for patients with chronic thromboembolic pulmonary hypertensionFabio Giuseppe Vassallo, Metka Kodric, Cleante Scarduelli, et al.Pageof 171